UnknownNot Applicable

Multidrug Resistant Shigella Infection in Bangladesh

Bangladesh2,000 participantsStarted 2018-12-13

Plain-language summary

The purpose of this project is to systematically collect clinical and nutritional outcomes information on patients treated for Shigella infection so that physicians and clinical laboratories can better define which Shigella infections are "resistant" to antibiotics and which are "susceptible", focusing on azithromycin a last-line drug to treat drug resistant Shigella

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diarrheal illness less than 96 hours duration * microscopic evidence of inflammatory diarrhea * plus mucus in stool * plus abdominal pain/cramps * Subject or parents or legal guardian willing to come for follow up at hospital or allow study staff for home visit * residence in Dhaka region * presentation during daytime hours Exclusion Criteria: • Not receiving treatment with azithromycin at enrolment

What they're measuring

Clinical outcome: resolution of diarrhea

Timeframe: Day 5

Trial details

NCT IDNCT03778125

SponsorUniversity of Virginia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Diarrhea trials